297 related articles for article (PubMed ID: 24574768)
1. Circulating and stool nucleic acid analysis for colorectal cancer diagnosis.
De Maio G; Rengucci C; Zoli W; Calistri D
World J Gastroenterol; 2014 Jan; 20(4):957-67. PubMed ID: 24574768
[TBL] [Abstract][Full Text] [Related]
2. Molecular detection of colorectal neoplasia.
Ahlquist DA
Gastroenterology; 2010 Jun; 138(6):2127-39. PubMed ID: 20420950
[TBL] [Abstract][Full Text] [Related]
3. Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Yörüker EE; Holdenrieder S; Gezer U
Clin Chim Acta; 2016 Apr; 455():26-32. PubMed ID: 26797671
[TBL] [Abstract][Full Text] [Related]
4. Stool DNA methylation assays in colorectal cancer screening.
Kadiyska T; Nossikoff A
World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
[TBL] [Abstract][Full Text] [Related]
5. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.
Ferracin M; Lupini L; Mangolini A; Negrini M
Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer: from prevention to personalized medicine.
Binefa G; Rodríguez-Moranta F; Teule A; Medina-Hayas M
World J Gastroenterol; 2014 Jun; 20(22):6786-808. PubMed ID: 24944469
[TBL] [Abstract][Full Text] [Related]
7. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
[TBL] [Abstract][Full Text] [Related]
8. Circulating free DNA in a screening program for early colorectal cancer detection.
Perrone F; Lampis A; Bertan C; Verderio P; Ciniselli CM; Pizzamiglio S; Frattini M; Nucifora M; Molinari F; Gallino G; Gariboldi M; Meroni E; Leo E; Pierotti MA; Pilotti S
Tumori; 2014; 100(2):115-21. PubMed ID: 24852853
[TBL] [Abstract][Full Text] [Related]
9. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
[TBL] [Abstract][Full Text] [Related]
10. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
Dollinger MM; Behl S; Fleig WE
Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
[TBL] [Abstract][Full Text] [Related]
11. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
12. Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening.
Anderson BW; Ahlquist DA
Gastroenterol Clin North Am; 2016 Sep; 45(3):529-42. PubMed ID: 27546847
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acids from intact epithelial cells as a target for stool-based molecular diagnosis of colorectal cancer.
Spethmann S; Fischer C; Wagener C; Streichert T; Tschentscher P
Int J Mol Med; 2004 Mar; 13(3):451-4. PubMed ID: 14767578
[TBL] [Abstract][Full Text] [Related]
14. New trends in molecular and cellular biomarker discovery for colorectal cancer.
Aghagolzadeh P; Radpour R
World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
[TBL] [Abstract][Full Text] [Related]
15. Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer.
Calistri D; Rengucci C; Molinari C; Ricci E; Cavargini E; Scarpi E; Milandri GL; Fabbri C; Ravaioli A; Russo A; Amadori D; Silvestrini R
Cell Oncol; 2009; 31(1):11-7. PubMed ID: 19096146
[TBL] [Abstract][Full Text] [Related]
16. Circulating nucleic acids as a tumor marker.
Chan KC; Lo YM
Histol Histopathol; 2002; 17(3):937-43. PubMed ID: 12168805
[TBL] [Abstract][Full Text] [Related]
17. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update.
Molnár B; Galamb O; Kalmár A; Barták BK; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Dank M
Expert Rev Mol Diagn; 2019 Jun; 19(6):477-498. PubMed ID: 31046485
[No Abstract] [Full Text] [Related]
18. Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.
Zhang H; Qi J; Wu YQ; Zhang P; Jiang J; Wang QX; Zhu YQ
World J Gastroenterol; 2014 Oct; 20(38):14040-50. PubMed ID: 25320544
[TBL] [Abstract][Full Text] [Related]
19. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.
Berger BM; Ahlquist DA
Pathology; 2012 Feb; 44(2):80-8. PubMed ID: 22198259
[TBL] [Abstract][Full Text] [Related]
20. [Free circulating DNA based colorectal cancer screening from peripheral blood: the possibility of the methylated septin 9 gene marker].
Tóth K; Galamb O; Spisák S; Wichmann B; Sipos F; Leiszter K; Molnár J; Molnár B; Tulassay Z
Orv Hetil; 2009 May; 150(21):969-77. PubMed ID: 19443305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
